Scholarly Index
Jesús G. Berdeja
Tennessee Oncology; 18,082 total citations; 442 total publications; best world rank #10
Tennessee Oncology
18,082Total citations
442Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 190 | US 99 | 98.82 |
| CAR-T cell therapy research | Lifetime | 408 | US 256 | 98.80 |
| Biosimilars and Bioanalytical Methods | Lifetime | 105 | US 38 | 97.84 |
| Protein Degradation and Inhibitors | Lifetime | 229 | US 139 | 98.15 |
| Histone Deacetylase Inhibitors Research | Lifetime | 622 | US 299 | 94.76 |
| CAR-T cell therapy research | 2021-2025 | 25 | US 13 | 99.76 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 22 | US 9 | 99.70 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 10 | US 5 | 98.95 |
| Protein Degradation and Inhibitors | 2021-2025 | 45 | US 21 | 99.05 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 181 | US 68 | 96.45 |
| Peptidase Inhibition and Analysis | 2021-2025 | 246 | US 75 | 94.71 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 660 | US 282 | 93.63 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 430 | US 123 | 83.21 |
| Biomedical Ethics and Regulation | 2021-2025 | 846 | US 335 | 57.24 |